Journal article
Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study
Abstract
BackgroundSeasonal vaccination is the mainstay of human influenza prevention. Licensed influenza vaccines are regularly updated to account for viral mutations and antigenic drift and are standardised for their haemagglutinin content. However, vaccine effectiveness remains suboptimal. Neuraminidase (NA) evolves more gradually than hemagglutinin and has been demonstrated to provide added clinical benefits. However, NA is not currently a mandated …
Authors
Youhanna J; Puig-Barberà J; Miller MS; Molrine D; Hadi M; Bapat S; Iheanacho I; Dodman S; Fikre T; Swinburn P
Journal
BMC Infectious Diseases, Vol. 25, No. 1,
Publisher
Springer Nature
DOI
10.1186/s12879-024-10277-4
ISSN
1471-2334